ISO/TC 212
| Registration number (WIID) | Project No. | Title | Status |
|---|---|---|---|
| 69802 | ISO 20166-2:2018 | Molecular in vitro diagnostic examinations — Specifications for pre-examinations processes for formalin-fixed and paraffin-embedded (FFPE) tissue — Part 2: Isolated proteins | Standarts spēkā |
| 88418 | ISO 35001:2019/Amd 1:2024 | Biorisk management for laboratories and other related organisations — Amendment 1: Climate action changes | Standarts spēkā |
| 67217 | ISO 20186-1:2019 | Molecular in vitro diagnostic examinations — Specifications for pre-examination processes for venous whole blood — Part 1: Isolated cellular RNA | Standarts spēkā |
| 51984 | ISO 19001:2013 | In vitro diagnostic medical devices — Information supplied by the manufacturer with in vitro diagnostic reagents for staining in biology | Standarts spēkā |
| 75442 | ISO 20166-4:2021 | Molecular in vitro diagnostic examinations — Specifications for preexamination processes for formalin-fixed and paraffin-embedded (FFPE) tissue — Part 4: In situ detection techniques | Standarts spēkā |
| 69445 | ISO/TS 20914:2019 | Medical laboratories — Practical guidance for the estimation of measurement uncertainty | Standarts spēkā |
| 78110 | ISO 20184-3:2021 | Molecular in vitro diagnostic examinations — Specifications for pre-examination processes for frozen tissue — Part 3: Isolated DNA | Standarts spēkā |
| 76677 | ISO 15189:2022 | Medical laboratories — Requirements for quality and competence | Standarts spēkā |
| 69799 | ISO 20186-2:2019 | Molecular in vitro diagnostic examinations — Specifications for pre-examination processes for venous whole blood — Part 2: Isolated genomic DNA | Standarts spēkā |
| 81712 | ISO/TS 5798:2022 | In vitro diagnostic test systems — Requirements and recommendations for detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by nucleic acid amplification methods | Standarts spēkā |
Displaying 31-40 of 146 results.